Cargando…
The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
Tawbi et al. (2021) have recently reported that nivolumab 1 mg/kg plus ipilimumab 3 mg/kg every 3 weeks for four doses (N1I3) provided durable survival for patients with active melanoma brain metastases without symptoms as first-line regimen. While we believe in the usefulness of the regimen propose...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126948/ https://www.ncbi.nlm.nih.gov/pubmed/35598383 http://dx.doi.org/10.1016/j.tranon.2022.101449 |